EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A hormone-dependent tRNA half promotes cell cycle progression via destabilization of p21 mRNA

Takuya Kawamura, Megumi Shigematsu, Yohei Kirino iD

PLOS Biology · 2025

DOI: 10.1371/journal.pbio.3003194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Takuya Kawamura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Computational Medicine Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase Inhibitor p21, RNA Stability, RNA, Messenger, Cell Cycle. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

tRNA halves are among the most abundant short non-coding RNAs in the cellular transcriptome. Here we report that in androgen receptor-positive LNCaP prostate cancer cells, the hormone-dependent 5′-tRNA LysCUU half promoted cell proliferation by facilitating cell cycle progression. Global mRNA profiling upon the 5′-tRNA LysCUU half depletion revealed that the mRNA of p21, a negative regulator of the cell cycle, is post-transcriptionally destabilized via a 5′-tRNA LysCUU half-driven mechanism. YBX1, identified as a protein interacting with 5′-tRNA LysCUU half in the cytosol, was shown to stabilize p21 mRNA. Specific sequences resembling the 5′-tRNA LysCUU half, located in the 3′-UTR of p21 mRNA and termed LL588, were identified as the binding site for YBX1 and are required for p21 mRNA stability. In vitro binding assays demonstrated that the 5′-tRNA LysCUU half is capable of displacing YBX1 from LL588. Collectively, our findings suggest that the 5′-tRNA LysCUU half directly binds to and displaces YBX1 from p21 mRNA, leading to the destabilization of p21 mRNA and the promotion of cell cycle progression in hormone-dependent cancers. Our study illuminates the role of tRNA halves in regulating mRNA stability and suggests that this may be part of broader regulatory networks affecting mRNA levels, orchestrated by various tRNA halves and their interacting proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase Inhibitor p21RNA StabilityRNA, MessengerCell CycleRNA, TransferHumansY-Box-Binding Protein 1Cell Line, TumorMaleCell ProliferationProstatic Neoplasms3' Untranslated RegionsGene Expression Regulation, Neoplastic

Substanzen

Cyclin-Dependent Kinase Inhibitor p21Y-Box-Binding Protein 1RNA, MessengerYBX1 protein, humanCDKN1A protein, humanRNA, Transfer3' Untranslated Regions

Autor:innen und Institutionen

  • Computational Medicine Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
  • Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.

ORCID-Profile: Yohei Kirino

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • American Cancer Society
  • W. W. Smith Charitable Trust
  • Japan Society for the Promotion of Science
  • National Cancer Institute

Zitieren

APA

Kawamura, T., Shigematsu, M., & Kirino, Y. (2025). A hormone-dependent tRNA half promotes cell cycle progression via destabilization of p21 mRNA. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003194

Vancouver

Kawamura T, Shigematsu M, Kirino Y. A hormone-dependent tRNA half promotes cell cycle progression via destabilization of p21 mRNA. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003194

BibTeX
@article{Kawamura2025,
  author = {Kawamura, Takuya and Shigematsu, Megumi and Kirino, Yohei},
  title = {A hormone-dependent tRNA half promotes cell cycle progression via destabilization of p21 mRNA},
  journal = {PLOS Biology},
  year = {2025},
  doi = {10.1371/journal.pbio.3003194}
}
Kostenlos starten →